HKD 15.94
(2.57%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 767.64 Million CNY | -4.32% |
2022 | 802.28 Million CNY | 31.13% |
2021 | 611.8 Million CNY | 75.47% |
2020 | 348.66 Million CNY | 51.36% |
2019 | 230.35 Million CNY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | - CNY | 0.0% |
2024 Q1 | - CNY | -100.0% |
2023 Q2 | 219.98 Thousand CNY | 0.0% |
2023 FY | 815.51 Million CNY | 1.65% |
2023 Q3 | 187.77 Thousand CNY | -14.64% |
2023 Q1 | 219.98 Thousand CNY | -16.88% |
2023 Q4 | 187.77 Thousand CNY | 0.0% |
2022 FY | 802.28 Million CNY | 31.13% |
2022 Q2 | 186.83 Thousand CNY | 0.0% |
2022 Q1 | 186.83 Thousand CNY | 1.11% |
2022 Q3 | 264.66 Thousand CNY | 41.66% |
2022 Q4 | 264.66 Thousand CNY | 0.0% |
2021 Q2 | 2.19 Million CNY | 0.0% |
2021 Q4 | 184.78 Thousand CNY | 0.0% |
2021 Q3 | 184.78 Thousand CNY | -91.59% |
2021 Q1 | 2.19 Million CNY | 748.76% |
2021 FY | 611.8 Million CNY | 75.47% |
2020 Q4 | 258.71 Thousand CNY | 0.0% |
2020 FY | 348.66 Million CNY | 51.36% |
2020 Q2 | 266.94 Thousand CNY | 0.0% |
2020 Q1 | 266.94 Thousand CNY | 0.0% |
2020 Q3 | 258.71 Thousand CNY | -3.08% |
2019 FY | 230.35 Million CNY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Uni-Bio Science Group Limited | 325.05 Million HKD | -136.163% |
CK Life Sciences Int'l., (Holdings) Inc. | 739.25 Million HKD | -3.841% |